Department of Traumatology and Orthopedic Surgery, Cologne-Merheim Medical Center (CMMC) Institute for Research in Operative Medicine (IFOM), University Witten-Herdecke, Cologne, Germany.
Expert Rev Hematol. 2020 Apr;13(4):323-330. doi: 10.1080/17474086.2020.1733404. Epub 2020 Feb 26.
: Uncontrolled hemorrhage with trauma-induced coagulopathy (TIC) still represents the most common cause of preventable death after trauma. Timely diagnosis and treatment including bleeding control and hemostatic resuscitation to correct TIC are important, as death from exsanguination occurs rapidly. Recognizing who requires an early massive transfusion together with the initiation of corresponding massive transfusion protocols (MTPs) is key to outcome.: This expert review summarizes the current state of MT including the activation and termination of MTPs, complications of MT, and strategies for refinement in the administration of blood products in order to avoid harmful over-transfusion.: MTPs should be initiated and continued until normal physiologic parameters are reached and definitive control of bleeding is achieved. Hospitals should develop their own MTPs, guided by evidence, and according to local infrastructure, logistics, needs and patient populations. Massive transfusion, defined as > 10 units of packed red blood cell concentrates (pRBCs) within the first 24 hours of hospital admission, can be life-saving, but is not without complications. MTPs are currently being refined through targeted and early goal-directed approaches which include functional coagulation testing assays to better guide the administration of blood products and hemostatic agents once the patient is stabilized.
创伤性凝血病(TIC)导致的不可控制的出血仍然是创伤后可预防死亡的最常见原因。及时诊断和治疗,包括出血控制和止血复苏以纠正 TIC,非常重要,因为失血过多导致的死亡发生得很快。识别哪些患者需要早期大量输血并启动相应的大量输血方案(MTP)是改善预后的关键。
这篇专家综述总结了 MT 的现状,包括 MTP 的激活和终止、MT 的并发症,以及改进血液制品管理的策略,以避免过度输血造成的危害。MTP 应在达到正常生理参数并实现出血控制的明确目标后启动并持续进行。医院应根据证据并根据当地基础设施、物流、需求和患者群体制定自己的 MTP。大量输血定义为入院后 24 小时内输注超过 10 单位浓缩红细胞(pRBC),可以救命,但并非没有并发症。MTP 目前正在通过有针对性和早期目标导向的方法进行改进,包括功能性凝血检测试验,以便在患者稳定后更好地指导血液制品和止血剂的使用。